BioMarin Pharma (BMRN) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY26 EPS Guidance
Go back to BioMarin Pharma (BMRN) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY26 EPS Guidance| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 54.69 -0.33 (0.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.02 | 52 Week High | $108.96 | |||
| Open | $55.04 | 52 Week Low | $62.12 | |||
| Day High | $55.62 | P/E | N/A | |||
| Day Low | $54.26 | EPS | $-1.27 | |||
| Volume | 3,481,466 | |||||
